| Name | Physiomics |
|---|---|
| Epic | PYC |
| Isin | GB00BDR6W943 |
| Industry | Medical Equipment and Services |
| Latest share price | 0.43p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £0.86 | Debt ratio | n/a |
| Shares in issue | 203.21 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -66.45 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.17 | 52-week high / low | 0.39p / 1.15p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Physiomics |
|---|---|
| Address | Milton Park Innovation Centre, 99 Park Drive, Milton Park, Oxfordshire, United Kingdom, OX14 4RY |
| Telephone | +44 (0) 186 5784 980 |
| Website | http://www.physiomics.co.uk/ |
| Director | Position |
|---|---|
| Dr Peter Sargent | CEO |
| Dr James Simon Millen | Non-Executive Chairman |
| Dr Timothy (Tim) Corn | Independent Non-Executive Director |
| Mr Shalabh Kumar | Independent Non-Executive Director |
| Assets £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Reporting date | 30/06/25 | 30/06/24 | 30/06/23 |
| Intangible asssets and goodwill | n/a | n/a | 0.01 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 0.02 | 0.02 | 0.01 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 0.41 | 0.21 | 0.24 |
| Cash and equivalents | 0.46 | 0.19 | 0.42 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 0.89 | 0.42 | 0.67 |
| Liabilities £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Short term liabilities | 0.2 | 0.14 | 0.14 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.2 | 0.14 | 0.14 |
| Net assets £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net assets | 0.69 | 0.28 | 0.53 |
| Equity £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Share capital | 2.11 | 1.44 | 1.28 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -7.81 | -7.43 | -6.84 |
| Share premium account | 6.27 | 6.12 | 5.94 |
| Total equity | 0.69 | 0.28 | 0.53 |
| Income £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -0.46 | -0.67 | -0.57 |
| Pre-tax profit | -0.46 | -0.67 | -0.57 |